Trials / Conditions / Melanoma Stage III or IV
Melanoma Stage III or IV
6 registered clinical trials studyying Melanoma Stage III or IV — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Enrolling By Invitation | CARDiac Toxicity Following ImmunOtherapy Treatment for Melanoma NCT06605833 | Royal Marsden NHS Foundation Trust | — |
| Active Not Recruiting | Different Doses of BI-1607 in Combination With Pembrolizumab and Ipilimumab, in Participants With Unresectable NCT06784648 | BioInvent International AB | Phase 1 / Phase 2 |
| Recruiting | Observational Study of Patients With Advanced Melanoma (Skin Cancer) to Assess if IOpener®-Melanoma Test Can P NCT06784778 | Pamgene International B.V. | — |
| Completed | Monocentric Pilot Study Investigating the Metabolic Activity of Melanoma in Vivo During Sorafenib and Dacarbaz NCT00794235 | University of Zurich | Phase 2 |
| Completed | Peptide-pulsed vs. RNA-transfected Dendritic Cell Vaccines in Melanoma Patients NCT00243529 | Radboud University Medical Center | Phase 1 / Phase 2 |
| Completed | Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection NCT00243594 | Radboud University Medical Center | Phase 1 / Phase 2 |